Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.570
+0.010 (0.64%)
At close: Oct 31, 2024, 4:00 PM
1.610
+0.039 (2.52%)
After-hours: Oct 31, 2024, 6:13 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $7.03 million as of October 31, 2024. Its market cap has decreased by -65.22% in one year.
Market Cap
7.03M
Enterprise Value
5.79M
1-Year Change
-65.22%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $411.31M to $7.03M, a decrease of -98.29%. That is a compound annual growth rate of -70.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 6.10M | -3.17% |
Dec 29, 2023 | 6.30M | -88.44% |
Dec 30, 2022 | 54.50M | -67.71% |
Dec 31, 2021 | 168.80M | -58.96% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Moleculin Biotech | 7.45M |
GT Biopharma | 7.37M |
Healthcare Triangle | 7.37M |
Purple Biotech | 7.31M |
Ontrak | 7.31M |
CNS Pharmaceuticals | 7.19M |
Syra Health | 7.06M |
Check-Cap | 6.90M |